National Research (NASDAQ:NRC - Get Free Report) released its earnings results on Monday. The company reported $0.28 earnings per share (EPS) for the quarter, Zacks reports. National Research had a return on equity of 67.40% and a net margin of 18.78%.
National Research Stock Up 4.3 %
Shares of NRC stock traded up $0.77 on Monday, hitting $18.73. The company's stock had a trading volume of 82,206 shares, compared to its average volume of 69,957. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The stock has a market capitalization of $439.78 million, a price-to-earnings ratio of 16.58 and a beta of 0.53. National Research has a fifty-two week low of $16.50 and a fifty-two week high of $42.00. The firm's fifty day moving average price is $18.15 and its 200-day moving average price is $20.24.
About National Research
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.